Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07244757
NA

Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

we aim to compare the analgesic efficacy of two intravenous ketorolac dosing regimens as part of a multimodal analgesic protocol that includes local wound infiltration for postoperative pain management after elective cesarean delivery.

Official title: Comparison of Two Dosing Regimens of Intravenous Ketorolac for Post-Cesarean Pain Control: A Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

126

Start Date

2025-12-01

Completion Date

2026-03

Last Updated

2026-01-13

Healthy Volunteers

No

Interventions

DRUG

Ketorolac 30 mg

administered intravenously as 30 mg diluted in 10 mL of normal saline and injected over more than 15 seconds

DRUG

Ketorolac 15mg

administered intravenously as either 15 mg diluted in 10 mL of normal saline and injected over more than 15 seconds.

Locations (1)

Kasr Alainy Hospital

Cairo, Egypt